NASDAQ:XNPT - XenoPort Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $7.07 0.00 (0.00 %) (As of 07/16/2018 04:00 PM ET)Previous Close$7.07Today's Range$7.07 - $7.0752-Week Range$3.35 - $7.86VolumeN/AAverage Volume1.22 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileFinancialsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email XenoPort, Inc. is a biopharmaceutical company. The Company is focused on commercializing HORIZANT (gabapentin enacarbil) Extended-Release Tablets in the United States. The Company's segment is the development and commercialization of product candidates for the treatment of neurological and other disorders. Its development-stage product candidates include XP23829, XP21279 and arbaclofen placarbil. HORIZANT has been approved by the United States Food and Drug Administration for the treatment of moderate-to-severe primary restless legs syndrome in adults and for the management of postherpetic neuralgia in adults. XP23829 is a fumaric acid ester compound and a prodrug of metabolite monomethyl fumarate being developed for the treatment for patients with moderate-to-severe chronic plaque-type psoriasis and/or patients with relapsing forms of multiple sclerosis. XP21279 is a Transported Prodrug of levodopa being developed for the treatment for patients with idiopathic Parkinson's disease. Receive XNPT News and Ratings via Email Sign-up to receive the latest news and ratings for XNPT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryPharmaceuticals SectorN/A SymbolNASDAQ:XNPT CUSIP98411C10 Webwww.xenoport.com Phone+1-408-6167200 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins-103.12% Return on Equity-414.36% Return on Assets-37.19% Miscellaneous EmployeesN/A Outstanding Shares63,520,000Market Cap$0.00 XenoPort (NASDAQ:XNPT) Frequently Asked Questions What is XenoPort's stock symbol? XenoPort trades on the NASDAQ under the ticker symbol "XNPT." How were XenoPort's earnings last quarter? XenoPort, Inc. (NASDAQ:XNPT) released its quarterly earnings data on Thursday, May, 5th. The biopharmaceutical company reported ($0.23) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.21) by $0.02. The biopharmaceutical company had revenue of $14.12 million for the quarter, compared to analysts' expectations of $14.24 million. XenoPort had a negative net margin of 103.12% and a negative return on equity of 414.36%. XenoPort's revenue for the quarter was up 99.7% compared to the same quarter last year. During the same period last year, the company earned ($0.33) earnings per share. View XenoPort's Earnings History. What is the consensus analysts' recommendation for XenoPort? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for XenoPort in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." Has XenoPort been receiving favorable news coverage? News headlines about XNPT stock have trended somewhat positive recently, according to Accern Sentiment. The research group identifies positive and negative press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. XenoPort earned a news impact score of 0.10 on Accern's scale. They also gave media coverage about the biopharmaceutical company an impact score of 45.85 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days. How do I buy shares of XenoPort? Shares of XNPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is XenoPort's stock price today? One share of XNPT stock can currently be purchased for approximately $7.07. How can I contact XenoPort? XenoPort's mailing address is 2000 Seaport Blvd Ste 300, REDWOOD CITY, CA 94063-5584, United States. The biopharmaceutical company can be reached via phone at +1-408-6167200. MarketBeat Community Rating for XenoPort (NASDAQ XNPT)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 130 (Vote Outperform)Underperform Votes: 114 (Vote Underperform)Total Votes: 244MarketBeat's community ratings are surveys of what our community members think about XenoPort and other stocks. Vote "Outperform" if you believe XNPT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XNPT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/16/2018 by MarketBeat.com StaffFeatured Article: Are analyst ratings accurate?